2-(Methoxycarbonyl)phenylboronic Acid (contains varying amounts of Anhydride)5g

tert-Butyl 2,5-Diazabicyclo[2.2.2]octane-2-carboxylate, 95.0%, 1g

[4-(Oxetan-3-yloxy)phenyl]methanamine hydrochloride, 1g

Methyl 3-((tert-butoxycarbonyl)amino)propanoate, 95.0%, 10g

N-benzyl-5-chloro-4-methyl-1,3-benzothiazol-2-amine, 95.0%, 250mg

GC-Kapillarsäule ROTI®Cap-1701 MS, L 30 m, Ø-Innen 0,25 mm, Filmd. 0,25 µm, 1 Stück

2'-O-(2-Methoxyethyl)-5-methyluridine>98.0%(HPLC)(qNMR)1g

13-Oxa-6,7-dithia-2,11-diazapentadecanoic acid, 3,10-dicarboxy-14,14-dimethyl-12-oxo-, 1-(1,1-dimethylethyl) ester, [R-(R*,R*)]- 9CI, ?97.0%, 100mg

3-Bromo-5-chlorobenzonitrile, 98.0%, 10g

MMT-Hexylaminolinker Phosphoramidite, 250mg

2-(4-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)thiazol-2-yl)acetonitrile, 98%, 250mg

6-Methyl-2-phenyl-1,3,6,2-dioxazaborocane-4,8-dione, 95%, 5g

2-Chloro-4,7-difluorobenzo[d]thiazole, 95.0%, 250mg